During the past decade, Nishinomiya Municipal Central Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nishinomiya Municipal Central Hospital" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Nishinomiya Municipal Central Hospital" are "Crohn's Disease" (3 trials), "Migraine" (3 trials), "Ulcerative Colitis" (3 trials), "Bone Metastasis" (1 trials) and "Cancer Pain" (1 trials). Many other conditions were trialed in "Nishinomiya Municipal Central Hospital" in a lesser frequency.

Most popular intervention types in "Nishinomiya Municipal Central Hospital" are "Drug" (9 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ontamalimab" (4 trials), "Lasmiditan" (3 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nishinomiya Municipal Central Hospital" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Nishinomiya Municipal Central Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Nishinomiya Municipal Central Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Nishinomiya Municipal Central Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".